The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NQZSA     1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,14Z)...

Synonyms: CHEMBL122972, BSPBio_001413, A8973_SIGMA, CHEBI:52392, HMDB04666, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-


Psychiatry related information on 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-


High impact information on 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-


Biological context of 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-


Anatomical context of 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-


Associations of 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)- with other chemical compounds


Gene context of 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-


Analytical, diagnostic and therapeutic context of 5,8,11,14-Eicosatetraenoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester, (all-Z)-

  • A facile total synthesis of 2-Ara-Gl was reported and an HPLC procedure for its identification and quantification was developed, but because of the instability of 2-Ara-Gl another synthesis was developed so that it can be stored as the more stable phenylboronate ester [29].


  1. Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue. Petersen, G., Moesgaard, B., Schmid, P.C., Schmid, H.H., Broholm, H., Kosteljanetz, M., Hansen, H.S. J. Neurochem. (2005) [Pubmed]
  2. Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa-induced dyskinesias. Ferrer, B., Asbrock, N., Kathuria, S., Piomelli, D., Giuffrida, A. Eur. J. Neurosci. (2003) [Pubmed]
  3. Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Di Marzo, V., De Petrocellis, L., Sugiura, T., Waku, K. Biochem. Biophys. Res. Commun. (1996) [Pubmed]
  4. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., Mechoulam, R. Eur. J. Pharmacol. (1998) [Pubmed]
  5. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Sinor, A.D., Irvin, S.M., Greenberg, D.A. Neurosci. Lett. (2000) [Pubmed]
  6. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Kirkham, T.C., Williams, C.M., Fezza, F., Di Marzo, V. Br. J. Pharmacol. (2002) [Pubmed]
  7. Endocannabinoids, feeding and suckling--from our perspective. Mechoulam, R., Berry, E.M., Avraham, Y., Di Marzo, V., Fride, E. International journal of obesity (2005) (2006) [Pubmed]
  8. Lipid signaling: sleep, synaptic plasticity, and neuroprotection. Chen, C., Bazan, N.G. Prostaglandins Other Lipid Mediat. (2005) [Pubmed]
  9. Endocannabinoids control the induction of cerebellar LTD. Safo, P.K., Regehr, W.G. Neuron (2005) [Pubmed]
  10. Endocannabinoids as physiological regulators of colonic propulsion in mice. Pinto, L., Izzo, A.A., Cascio, M.G., Bisogno, T., Hospodar-Scott, K., Brown, D.R., Mascolo, N., Di Marzo, V., Capasso, F. Gastroenterology (2002) [Pubmed]
  11. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M.G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E.J., Gangadharan, U., Hobbs, C., Di Marzo, V., Doherty, P. J. Cell Biol. (2003) [Pubmed]
  12. The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response. Williams, E.J., Walsh, F.S., Doherty, P. J. Cell Biol. (2003) [Pubmed]
  13. The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Nirodi, C.S., Crews, B.C., Kozak, K.R., Morrow, J.D., Marnett, L.J. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  14. Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Chen, Y., McCarron, R.M., Ohara, Y., Bembry, J., Azzam, N., Lenz, F.A., Shohami, E., Mechoulam, R., Spatz, M. Circ. Res. (2000) [Pubmed]
  15. Generation of diacylglycerol molecular species through the cell cycle: a role for 1-stearoyl, 2-arachidonyl glycerol in the activation of nuclear protein kinase C-betaII at G2/M. Deacon, E.M., Pettitt, T.R., Webb, P., Cross, T., Chahal, H., Wakelam, M.J., Lord, J.M. J. Cell. Sci. (2002) [Pubmed]
  16. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. Ouyang, Y., Hwang, S.G., Han, S.H., Kaminski, N.E. Mol. Pharmacol. (1998) [Pubmed]
  17. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Bl??her, M., Engeli, S., Kl??ting, N., Berndt, J., Fasshauer, M., B??tkai, S., Pacher, P., Sch??n, M.R., Jordan, J., Stumvoll, M. Diabetes (2006) [Pubmed]
  18. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. Wagner, J.A., Hu, K., Bauersachs, J., Karcher, J., Wiesler, M., Goparaju, S.K., Kunos, G., Ertl, G. J. Am. Coll. Cardiol. (2001) [Pubmed]
  19. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Saario, S.M., Salo, O.M., Nevalainen, T., Poso, A., Laitinen, J.T., Järvinen, T., Niemi, R. Chem. Biol. (2005) [Pubmed]
  20. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. van der Stelt, M., Mazzola, C., Esposito, G., Matias, I., Petrosino, S., De Filippis, D., Micale, V., Steardo, L., Drago, F., Iuvone, T., Di Marzo, V. Cell. Mol. Life Sci. (2006) [Pubmed]
  21. Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. Kozak, K.R., Rowlinson, S.W., Marnett, L.J. J. Biol. Chem. (2000) [Pubmed]
  22. PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. Sang, N., Zhang, J., Chen, C. J. Physiol. (Lond.) (2006) [Pubmed]
  23. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. Lee, M., Yang, K.H., Kaminski, N.E. J. Pharmacol. Exp. Ther. (1995) [Pubmed]
  24. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry. Richardson, D., Ortori, C.A., Chapman, V., Kendall, D.A., Barrett, D.A. Anal. Biochem. (2007) [Pubmed]
  25. Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids. Steffens, M., Schulze-Bonhage, A., Surges, R., Feuerstein, T.J. Neurosci. Lett. (2005) [Pubmed]
  26. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol. Kozak, K.R., Prusakiewicz, J.J., Rowlinson, S.W., Schneider, C., Marnett, L.J. J. Biol. Chem. (2001) [Pubmed]
  27. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Gonsiorek, W., Lunn, C., Fan, X., Narula, S., Lundell, D., Hipkin, R.W. Mol. Pharmacol. (2000) [Pubmed]
  28. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. Sipe, J.C., Arbour, N., Gerber, A., Beutler, E. J. Leukoc. Biol. (2005) [Pubmed]
  29. Recent advances in the synthesis of endocannabinoid related ligands. Razdan, R.K., Mahadevan, A. Chem. Phys. Lipids (2002) [Pubmed]
WikiGenes - Universities